3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lung Neoplasms
1
Interventions
pembrolizumab
5
Cisplatin
5
Platinum
4
Pemetrexed
4
1,2-diaminocyclohexaneplatinum II citrate
4
Nivolumab
3
Cyclophosphamide
3
fludarabine
2
atezolizumab
2
Ipilimumab
2
Carboplatin
2
tremelimumab
1
sargramostim
1
methoxyamine
1
lenvatinib
1
cediranib
1
anetumab ravtansine
1
UV1 vaccine
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiation
1
Interleukin-2
1
Imprint II
1
Immunotherapy, Adoptive
1
Immunoglobulin G
1
Gemcitabine
1
Disulfides
1
Bevacizumab
1
BAY 1895344
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Mesothelioma, Malignant
×
UV1 vaccine
×
Clear all
NCT04300244
2024-02-29
NIPU
Oslo University Hospital
Phase 2
Active not recruiting
118 enrolled